Stock Analysis on Net

Monsanto Co. (NYSE:MON)

$22.49

This company has been moved to the archive! The financial data has not been updated since April 5, 2018.

Economic Value Added (EVA)

Microsoft Excel

EVA is registered trademark of Stern Stewart.

Economic value added or economic profit is the difference between revenues and costs,where costs include not only expenses, but also cost of capital.

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Economic Profit

Monsanto Co., economic profit calculation

US$ in millions

Microsoft Excel
12 months ended: Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014 Aug 31, 2013 Aug 31, 2012
Net operating profit after taxes (NOPAT)1
Cost of capital2
Invested capital3
 
Economic profit4

Based on: 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31), 10-K (reporting date: 2013-08-31), 10-K (reporting date: 2012-08-31).

1 NOPAT. See details »

2 Cost of capital. See details »

3 Invested capital. See details »

4 2017 Calculation
Economic profit = NOPAT – Cost of capital × Invested capital
= × =


The period under review demonstrates fluctuating financial performance as measured by economic profit. Net operating profit after taxes (NOPAT) exhibits variability, while the cost of capital generally decreases before increasing slightly in the final year. Invested capital also shows fluctuations, impacting the overall economic profit calculation.

NOPAT Trend
Net operating profit after taxes increased from US$2,247 million in 2012 to US$2,743 million in 2013. This was followed by a decrease to US$2,633 million in 2014, then a further decline to US$2,361 million in 2015. A significant drop to US$1,816 million occurred in 2016, before a recovery to US$2,582 million in 2017. This suggests operational performance is subject to considerable year-to-year variation.
Cost of Capital Trend
The cost of capital began at 18.67% in 2012, increasing to 18.82% in 2013. A decreasing trend followed, reaching 16.45% in 2015. The cost of capital then rose slightly to 16.50% in 2016 and further to 17.14% in 2017. These changes may reflect shifts in market conditions or the company’s capital structure.
Invested Capital Trend
Invested capital increased from US$14,553 million in 2012 to US$15,770 million in 2013 and continued to rise to US$16,260 million in 2014. A substantial increase to US$18,327 million occurred in 2015, followed by a decrease to US$15,963 million in 2016. Invested capital then increased modestly to US$16,366 million in 2017. These fluctuations indicate changes in the company’s asset base and funding requirements.
Economic Profit Trend
Economic profit was negative throughout the observed period. The initial loss of US$470 million in 2012 improved to a loss of US$226 million in 2013, and further to a loss of US$169 million in 2014. However, economic profit deteriorated significantly to a loss of US$655 million in 2015 and reached its largest loss of US$817 million in 2016. A partial recovery occurred in 2017, with economic profit decreasing to a loss of US$224 million. The consistently negative economic profit suggests that the company’s returns are not exceeding its cost of capital, despite the NOPAT recovery in the final year.

The interplay between NOPAT, cost of capital, and invested capital results in a volatile economic profit profile. While NOPAT demonstrates some recovery towards the end of the period, the consistently negative economic profit indicates that the company is not generating returns sufficient to cover its capital costs.


Net Operating Profit after Taxes (NOPAT)

Monsanto Co., NOPAT calculation

US$ in millions

Microsoft Excel
12 months ended: Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014 Aug 31, 2013 Aug 31, 2012
Net income attributable to Monsanto Company
Deferred income tax expense (benefit)1
Increase (decrease) in allowance for doubtful trade receivables2
Increase (decrease) in LIFO reserve3
Increase (decrease) in deferred revenues4
Increase (decrease) in restructuring reserves5
Increase (decrease) in equity equivalents6
Interest expense
Interest expense, operating lease liability7
Adjusted interest expense
Tax benefit of interest expense8
Adjusted interest expense, after taxes9
(Gain) loss on marketable securities
Interest income
Investment income, before taxes
Tax expense (benefit) of investment income10
Investment income, after taxes11
(Income) loss from discontinued operations, net of tax12
Net income (loss) attributable to noncontrolling interest
Net operating profit after taxes (NOPAT)

Based on: 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31), 10-K (reporting date: 2013-08-31), 10-K (reporting date: 2012-08-31).

1 Elimination of deferred tax expense. See details »

2 Addition of increase (decrease) in allowance for doubtful trade receivables.

3 Addition of increase (decrease) in LIFO reserve. See details »

4 Addition of increase (decrease) in deferred revenues.

5 Addition of increase (decrease) in restructuring reserves.

6 Addition of increase (decrease) in equity equivalents to net income attributable to Monsanto Company.

7 2017 Calculation
Interest expense on capitalized operating leases = Operating lease liability × Discount rate
= × =

8 2017 Calculation
Tax benefit of interest expense = Adjusted interest expense × Statutory income tax rate
= × 35.00% =

9 Addition of after taxes interest expense to net income attributable to Monsanto Company.

10 2017 Calculation
Tax expense (benefit) of investment income = Investment income, before tax × Statutory income tax rate
= × 35.00% =

11 Elimination of after taxes investment income.

12 Elimination of discontinued operations.


The financial data reveals certain trends in profitability for the analyzed company over a six-year period ending August 31, 2017.

Net Income Attributable to the Company

Net income shows an overall fluctuating pattern across the years. It increased steadily from 2045 million US dollars in 2012 to a peak of 2740 million in 2014. Subsequently, it experienced a decline to 2314 million in 2015 and a more pronounced decrease to 1336 million in 2016, indicating a significant setback in profitability during that year. However, the net income rebounded sharply to 2260 million in 2017, signaling recovery but not reaching the earlier peak levels.

Net Operating Profit After Taxes (NOPAT)

NOPAT similarly experienced variations over the examined period. It rose from 2247 million USD in 2012 to 2743 million in 2013, before slightly declining to 2633 million in 2014. The value then decreased further to 2361 million in 2015 and took a more substantial fall to 1816 million in 2016. In 2017, NOPAT saw a notable recovery to 2582 million. This suggests operational efficiency or profitability challenges during 2015 and 2016 with improvement thereafter.

Overall, both net income and NOPAT indicate a peak generally around 2013-2014, followed by declines in 2015 and notably in 2016. The recovery in 2017 reflects a positive turnaround. The inconsistency observed in both metrics suggests volatility in profitability and operational performance during these years, highlighting a period of financial challenges mid-cycle with subsequent recovery efforts yielding results by the final year reported.


Cash Operating Taxes

Monsanto Co., cash operating taxes calculation

US$ in millions

Microsoft Excel
12 months ended: Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014 Aug 31, 2013 Aug 31, 2012
Income tax provision from continuing operations
Less: Deferred income tax expense (benefit)
Add: Tax savings from interest expense
Less: Tax imposed on investment income
Cash operating taxes

Based on: 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31), 10-K (reporting date: 2013-08-31), 10-K (reporting date: 2012-08-31).


Income Tax Provision from Continuing Operations
The income tax provision from continuing operations exhibited a fluctuating trend over the six-year period. Starting at 901 million USD in 2012, a slight increase to 915 million USD was observed in 2013. This upward movement continued more notably in 2014, reaching a peak of 1,078 million USD. However, the subsequent years showed a declining pattern: it decreased to 864 million USD in 2015, further dropped to 695 million USD in 2016, and reached its lowest point at 626 million USD in 2017. Overall, despite an initial rise until 2014, the income tax provision has generally declined in the latter part of the timeframe.
Cash Operating Taxes
Cash operating taxes demonstrated more volatility relative to the income tax provision. Beginning at 708 million USD in 2012, there was a steady increase to 821 million USD in 2013, followed by a substantial spike to 1,179 million USD in 2014. The upward trend continued into 2015, peaking at 1,272 million USD. However, unlike income tax provision, cash operating taxes experienced a sharp decrease in 2016, falling to 801 million USD, and then a further decline to 719 million USD by 2017. Despite the fluctuations, the values at the end of the period remained higher than the initial 2012 figures.
Comparative Observations
Both income tax provision and cash operating taxes display a pattern of increasing values through the early years, reaching peaks around 2014 or 2015, followed by a notable decline in the last two years. The cash operating taxes showed more pronounced increases and decreases compared to the income tax provision, suggesting greater variability in actual tax cash outflows relative to the accounting provisions. The consistent decline in both items after 2015 might indicate changes in tax strategy, operational performance, or tax regulations affecting the company's tax liabilities.

Invested Capital

Monsanto Co., invested capital calculation (financing approach)

US$ in millions

Microsoft Excel
Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014 Aug 31, 2013 Aug 31, 2012
Short-term debt, including current portion of long-term debt
Long-term debt, excluding current portion
Operating lease liability1
Total reported debt & leases
Total Monsanto Company shareowners’ equity
Net deferred tax (assets) liabilities2
Allowance for doubtful trade receivables3
Excess of FIFO over LIFO cost4
Deferred revenues5
Restructuring reserves6
Equity equivalents7
Accumulated other comprehensive (income) loss, net of tax8
Noncontrolling interest
Adjusted total Monsanto Company shareowners’ equity
Construction in progress and other9
Investments10
Invested capital

Based on: 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31), 10-K (reporting date: 2013-08-31), 10-K (reporting date: 2012-08-31).

1 Addition of capitalized operating leases.

2 Elimination of deferred taxes from assets and liabilities. See details »

3 Addition of allowance for doubtful accounts receivable.

4 Addition of LIFO reserve. See details »

5 Addition of deferred revenues.

6 Addition of restructuring reserves.

7 Addition of equity equivalents to total Monsanto Company shareowners’ equity.

8 Removal of accumulated other comprehensive income.

9 Subtraction of construction in progress and other.

10 Subtraction of investments.


The financial data reveals several important trends and shifts over the six-year period ending August 31, 2017.

Total reported debt & leases
This metric shows a notable increase from 2012 through 2015, rising sharply from approximately $2.4 billion to $9.5 billion. The peak occurs in 2015 with a slight decline thereafter, dropping to $8.6 billion by 2017. This suggests a significant increase in leverage or borrowing activities during the mid-period, followed by some reduction in debt levels.
Total Monsanto Company shareowners’ equity
Shareowners’ equity exhibits a declining trend over the years. Starting at about $11.8 billion in 2012, equity increases slightly in 2013 but then declines steadily to a low of $4.5 billion in 2016. A partial recovery to $6.4 billion in 2017 is observed. This decreasing equity position alongside rising debt levels in the earlier years indicates possible financial restructuring or share buybacks impacting the equity base.
Invested capital
Invested capital shows a general upward trend from 2012 through 2015, rising from approximately $14.6 billion to $18.3 billion before declining to around $16.0 billion in 2016. A slight increase to $16.4 billion in 2017 occurs. The growth in invested capital up to 2015 parallels the increases in both debt and equity during that period, suggesting expansion or acquisition initiatives. The subsequent decrease and stabilization may reflect a period of consolidation or reevaluation of capital investment.

Overall, the data suggest that the company experienced increased leverage with a peak in debt around 2015, accompanied by declining shareholders’ equity after 2013. Despite fluctuations, invested capital remained relatively high, implying continued commitment to the company's operational base or growth efforts. The partial recovery in equity and reduction in debt post-2015 could indicate a strategic shift towards strengthening the balance sheet and deleveraging.


Cost of Capital

Monsanto Co., cost of capital calculations

Capital (fair value)1 Weights Cost of capital
Equity2 ÷ = × =
Debt3 ÷ = × × (1 – 35.00%) =
Operating lease liability4 ÷ = × × (1 – 35.00%) =
Total:

Based on: 10-K (reporting date: 2017-08-31).

1 US$ in millions

2 Equity. See details »

3 Debt. See details »

4 Operating lease liability. See details »

Capital (fair value)1 Weights Cost of capital
Equity2 ÷ = × =
Debt3 ÷ = × × (1 – 35.00%) =
Operating lease liability4 ÷ = × × (1 – 35.00%) =
Total:

Based on: 10-K (reporting date: 2016-08-31).

1 US$ in millions

2 Equity. See details »

3 Debt. See details »

4 Operating lease liability. See details »

Capital (fair value)1 Weights Cost of capital
Equity2 ÷ = × =
Debt3 ÷ = × × (1 – 35.00%) =
Operating lease liability4 ÷ = × × (1 – 35.00%) =
Total:

Based on: 10-K (reporting date: 2015-08-31).

1 US$ in millions

2 Equity. See details »

3 Debt. See details »

4 Operating lease liability. See details »

Capital (fair value)1 Weights Cost of capital
Equity2 ÷ = × =
Debt3 ÷ = × × (1 – 35.00%) =
Operating lease liability4 ÷ = × × (1 – 35.00%) =
Total:

Based on: 10-K (reporting date: 2014-08-31).

1 US$ in millions

2 Equity. See details »

3 Debt. See details »

4 Operating lease liability. See details »

Capital (fair value)1 Weights Cost of capital
Equity2 ÷ = × =
Debt3 ÷ = × × (1 – 35.00%) =
Operating lease liability4 ÷ = × × (1 – 35.00%) =
Total:

Based on: 10-K (reporting date: 2013-08-31).

1 US$ in millions

2 Equity. See details »

3 Debt. See details »

4 Operating lease liability. See details »

Capital (fair value)1 Weights Cost of capital
Equity2 ÷ = × =
Debt3 ÷ = × × (1 – 35.00%) =
Operating lease liability4 ÷ = × × (1 – 35.00%) =
Total:

Based on: 10-K (reporting date: 2012-08-31).

1 US$ in millions

2 Equity. See details »

3 Debt. See details »

4 Operating lease liability. See details »


Economic Spread Ratio

Monsanto Co., economic spread ratio calculation, comparison to benchmarks

Microsoft Excel
Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014 Aug 31, 2013 Aug 31, 2012
Selected Financial Data (US$ in millions)
Economic profit1
Invested capital2
Performance Ratio
Economic spread ratio3
Benchmarks
Economic Spread Ratio, Competitors4
lululemon athletica inc.
Nike Inc.

Based on: 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31), 10-K (reporting date: 2013-08-31), 10-K (reporting date: 2012-08-31).

1 Economic profit. See details »

2 Invested capital. See details »

3 2017 Calculation
Economic spread ratio = 100 × Economic profit ÷ Invested capital
= 100 × ÷ =

4 Click competitor name to see calculations.


The economic spread ratio exhibited fluctuations over the observed period. Initially negative, the ratio demonstrated improvement before declining significantly and then showing a degree of recovery. Economic profit consistently remained negative throughout the period, though with varying magnitudes.

Economic Spread Ratio
The economic spread ratio began at -3.23% in 2012 and improved to -1.43% in 2013, indicating a lessening of the gap between return on invested capital and the cost of capital. However, the ratio deteriorated substantially to -3.57% in 2015, and further to -5.12% in 2016, representing the largest negative spread during the period. A partial recovery was observed in 2017, with the ratio increasing to -1.37%. This suggests a cyclical pattern of performance relative to the cost of capital.
Economic Profit
Economic profit moved from -470 million in 2012 to -226 million in 2013, mirroring the improvement in the economic spread ratio. The largest negative economic profit occurred in 2015 at -655 million, coinciding with the most negative economic spread ratio. A decrease in the magnitude of the loss was seen in 2016 (-817 million) before a substantial improvement to -224 million in 2017. This indicates that while the company consistently failed to generate economic profit, the scale of the loss varied considerably.
Invested Capital
Invested capital generally increased from 14,553 million in 2012 to 18,327 million in 2015. A decrease was then observed in 2016 to 15,963 million, followed by a slight increase to 16,366 million in 2017. The fluctuations in invested capital do not appear to directly correlate with the changes in economic profit or the economic spread ratio, suggesting other factors are influencing profitability.

Overall, the period was characterized by consistent negative economic profit. While there were periods of improvement in the economic spread ratio, the company consistently failed to generate returns exceeding its cost of capital. The substantial decline in the economic spread ratio in 2015 and 2016 warrants further investigation to understand the underlying drivers.


Economic Profit Margin

Monsanto Co., economic profit margin calculation, comparison to benchmarks

Microsoft Excel
Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014 Aug 31, 2013 Aug 31, 2012
Selected Financial Data (US$ in millions)
Economic profit1
 
Net sales
Add: Increase (decrease) in deferred revenues
Adjusted net sales
Performance Ratio
Economic profit margin2
Benchmarks
Economic Profit Margin, Competitors3
lululemon athletica inc.
Nike Inc.

Based on: 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31), 10-K (reporting date: 2013-08-31), 10-K (reporting date: 2012-08-31).

1 Economic profit. See details »

2 2017 Calculation
Economic profit margin = 100 × Economic profit ÷ Adjusted net sales
= 100 × ÷ =

3 Click competitor name to see calculations.


The economic profit margin exhibited considerable fluctuation between 2012 and 2017. While adjusted net sales generally remained stable, economic profit demonstrated volatility, directly impacting the economic profit margin.

Economic Profit Margin Trend
The economic profit margin began at -3.50% in 2012, improved to -1.52% in 2013, and continued to improve to -1.08% in 2014. A significant decline was then observed in 2015, with the margin falling to -4.38%. This downward trend continued into 2016, reaching a low of -5.97%. The margin experienced a partial recovery in 2017, increasing to -1.51%.
Relationship to Economic Profit
The economic profit margin’s movements closely mirrored those of economic profit. The largest negative economic profit value, recorded in 2016 at -817 US$ millions, corresponded with the most negative economic profit margin of -5.97%. Conversely, the smallest negative economic profit in 2013 (-226 US$ millions) coincided with the least negative margin of -1.52%.
Relationship to Adjusted Net Sales
Adjusted net sales showed a general increase from 2012 to 2014, peaking at 15,685 US$ millions. A decrease was then noted in 2015 and 2016, before a slight recovery in 2017. However, the fluctuations in adjusted net sales do not appear to be the primary driver of the economic profit margin’s volatility; the margin’s changes are more strongly correlated with the changes in economic profit.

Overall, the period under review was characterized by inconsistent economic profitability, as reflected in the fluctuating economic profit margin. While sales remained relatively stable, the company’s ability to generate economic profit varied significantly year to year.